Literature DB >> 9843024

Granulomatous dermatitis with focal sarcoidal features associated with recombinant interferon beta-1b injections.

C L Mehta1, R J Tyler, D J Cripps.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9843024     DOI： 10.1016/s0190-9622(98)70285-3

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  5 in total

Review 1.  Managing the adverse effects of interferon-beta therapy in multiple sclerosis.

Authors:  A Bayas; P Rieckmann
Journal:  Drug Saf       Date:  2000-02       Impact factor: 5.606

Review 2.  Cutaneous Adverse Effects of Neurologic Medications.

Authors:  Eman Bahrani; Chloe E Nunneley; Sylvia Hsu; Joseph S Kass
Journal:  CNS Drugs       Date:  2016-03       Impact factor: 6.497

3.  Cutaneous and pulmonary sarcoidosis following treatment of multiple sclerosis with interferon-β-1b: a case report.

Authors:  Mohammad Ali Sahraian; Abdorreza Naser Moghadasi; Mahsa Owji; Mehrdad Maboudi; Farid Kosari; Jeanie C McGee; Alireza Minagar
Journal:  J Med Case Rep       Date:  2013-12-13

4.  Bone marrow sarcoidosis associated with long-term interferon-β treatment for multiple sclerosis.

Authors:  Angela Teh; Patrick Russell; Jordan Li; Udul Hewage
Journal:  Clin Case Rep       Date:  2016-09-27

5.  Pegylated Interferon-Induced Sarcoidosis Presenting With Anterior Uveitis in a Patient with Chronic Hepatitis C - Case Report.

Authors:  A M Kamal; P Mitruț; C K Kamal; D O Alexandru; A Tica
Journal:  Curr Health Sci J       Date:  2015-12-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.